Pharmaceutical composition and preparation method thereof

A composition and medicine technology, applied in the field of pharmaceutical compositions and their preparation, can solve the problems of long course of treatment, low cure rate and the like, and achieve the effect of less toxic and side effects

Inactive Publication Date: 2008-10-29
郭维宪
View PDF0 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Existing treatment methods have a long course of treatment and a low cure rate

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] A pharmaceutical composition for treating hepatitis A, hepatitis B and liver cirrhosis, comprising raw materials and parts by weight thereof as follows:

[0034] Impatient 100; Polygonum cuspidatum 170; See wearing 120; Turmeric 150;

[0035] Danshen 150; Turtle Shell 100; Panax notoginseng 120; Curcuma 150;

[0036] Prunella vulgaris 800; Qingpi 150; Sophora flavescens 100; Coix seed 170;

[0037] white cardamom 800; red peony 220; gentian 80; scutellaria baicalensis 170;

[0038] Wuwei 180; Viola 150; Patrinia 120; Bupleurum 150;

[0039] Peilan 100; Desmodium 170; Banlangen 220; Artemisia annua 600;

[0040] Huoxiang 400; Tortoise shell 100; Ginger silkworm 100; Poria cocos 150;

[0041] Polyporus 160; Radix Ginseng 150; Part 120; Polygonatum 120;

[0042] Cistanche 180; Rhubarb 120; Hawthorn 220; Woody 520;

[0043] Houpu 100; Fungus Ganoderma lucidum 220; Ziheche 120; Red Ant 220;

[0044] Paeoniae Alba 180; Pig Tooth Soap 120.

[0045] The preparation meth...

Embodiment 2

[0049] A pharmaceutical composition for treating hepatitis A, hepatitis B and liver cirrhosis, comprising raw materials and parts by weight thereof as follows:

[0050] Impatient 150; Polygonum cuspidatum 120; Ishi Jianchuan 170; Turmeric 100;

[0051] Danshen 200; Turtle Shell 50; Panax notoginseng 170; Curcuma 100;

[0052] Prunella vulgaris 120; Qingpi 100; Sophora flavescens 150; Coix seed 120;

[0053] White cardamom 120; Radix Paeoniae Rubra 180; Gentiana 120; Scutellaria baicalensis 120;

[0054] Wuwei 220; Zihuadiding 100; Patrinia 170; Bupleurum 100;

[0055] Peilan 150; Desmodium 120; Banlangen 270; Artemisia annua 400;

[0056] Huoxiang 600; Tortoise shell 50; Ginger silkworm 150; Poria cocos 100;

[0057] Polyporus 240; Adenophora 100; Baibu 170; Polygonatum 80;

[0058] Cistanche 220; Rhubarb 80; Hawthorn 270; Woody fragrance 180;

[0059] Houpu 140; Fungus Ganoderma lucidum 180; Ziheche 170; Red Ant 180;

[0060] Radix Paeoniae Alba 220; Pig Tooth Soap 80....

Embodiment 3

[0065] A pharmaceutical composition for treating hepatitis A, hepatitis B and liver cirrhosis, comprising raw materials and parts by weight thereof as follows:

[0066] Impatient 125; Polygonum cuspidatum 150; Ishi Jianchuan 150; Turmeric 125;

[0067] Danshen 175; Turtle Shell 75; Panax notoginseng 150; Yujin 125;

[0068] Prunella vulgaris 100; Qingpi 125; Sophora flavescens 125; Coix seed 150;

[0069] white cardamom 100; red peony 200; gentian 100; skullcap 150;

[0070] Wuwei 200; Zihuadiding 125; Patrinia 150; Bupleurum 125;

[0071] Peilan 125; Desmodium 150; Banlangen 250; Artemisia annua 500;

[0072]Huoxiang 500; Tortoise shell 75; Ginger silkworm 125; Poria cocos 125;

[0073] Polyporus 200; Adenophora 125; Baibu 150; Polygonatum 100;

[0074] Cistanche 200; Rhubarb 100; Hawthorn 250; Woody 500;

[0075] Houpu 120; Fungus Ganoderma lucidum 200; Ziheche 150; Red Ant 200;

[0076] Paeoniae Alba 200; Pig Tooth Soap 100.

[0077] The preparation method of the ab...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a pharmaceutical composition for treating hepatitis A, hepatitis B and liver cirrhosis, and a preparation method thereof. The invention provides the pharmaceutical composition for treating hepatitis A, hepatitis B and liver cirrhosis, comprising the following raw materials: garden balsam, giant knotweed rhizome, Chinese sage herb, turmeric, danshen root, turtle shell, sanchi, turmeric root-tuber, common selfheal fruit-spike, green tangerine peel, lightyellow sophora root, coix seed, round cardamom fruit, red paeony root, Chinese gentian, baical skullcap root, Chinese magnoliavine fruit, Philippine violet herb, dahurian patrinia herb, Chinese thorowax root, fortune eupatorium herb, longhairy antenoron herb, Indigowoad root, sweet wormwood herb, wrinkled gianthyssop herb, turtle shell, stiff silkworm, Indian buead, agaric, coastal glehnia root, sessile stemona root, rhizome, desertliving cistanche, rhubarb, hawthorn fruit, costustoot, officinal magnolia bark, lucid ganoderma, human placenta, red ant, white paeony root and Chinese honeylocust abnormal fruit. The invention further provides the preparation method of the pharmaceutical composition. The pharmaceutical composition provided by the invention has insignificant toxicity and side effects, remarkable efficacy and difficult recurrence.

Description

technical field [0001] The invention relates to a pharmaceutical composition for treating hepatitis A, hepatitis B and liver cirrhosis and a preparation method thereof. Background technique [0002] Hepatitis A, hepatitis B and liver cirrhosis are common and frequently-occurring diseases, and they are highly contagious and difficult to cure. The existing treatment method has a long course of treatment and a low cure rate. Contents of the invention [0003] Aiming at the defects of the current treatment methods for hepatitis A, hepatitis B and liver cirrhosis, the invention provides a new pharmaceutical composition for treating hepatitis A, hepatitis B and liver cirrhosis. [0004] Technical scheme of the present invention is as follows: [0005] The invention provides a pharmaceutical composition for treating hepatitis A, hepatitis B and liver cirrhosis, comprising raw materials and parts by weight as follows: [0006] Impatient 100-150; Polygonum cuspidatum 120-170; Is...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/9066A61P1/16A61P31/14A61P31/20A61K35/64A61K35/56A61K35/50A61K35/586
CPCY02A50/30
Inventor 郭维宪
Owner 郭维宪
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap